Your Article Summary
See Latest ArticlesEuropean CHMP Adopts Positive Opinion for Aztreonam Lysine
Gilead, 06/29/09
Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company's Marketing Authorisation Application for aztreonam lysine 75 mg powder and solvent for nebuliser solution for the suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 18 years and older. The opinion is for conditional approval, contingent on the successful completion of an ongoing study.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytokinetics to Present Non-Clinical Data Relating to CK-2017357 at the 5th Cachexia Conference
Cytokinetics, 12/01/09
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 to be Presented at the 2009 American Society of Hematology Annual Meeting and Exposition
Cytokinetics, 12/01/09
Amgen Highlights Data to be Presented at ASH
Amgen, 12/01/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09